Childhood Arthritis and Rheumatology Research Alliance Biologic DMARD Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.

Stacey E TarvinMatthew A Sherman Hanna KimNayimisha BalmuriAmanda G BrownAlbert ChowHarry L GewanterMarietta M de GuzmanAdam M HuberSusan KimMarisa S Klein-GitelmanMegan Mariko PerronAngela Byun RobinsonSara E SabbaghSonia SavaniSusan ShenoiJacob SpitznagleCory StinglGrant SyversonHeather ToryCharles Spencernull null

Published in: Arthritis care & research (2024)

CTPs for the use of bDMARDs in refractory moderately severe JDM were developed using consensus methodology. The implementation of the bDMARD CTPs will lay the groundwork for registry-based prospective comparative effectiveness studies.

Keyphrases

rheumatoid arthritis
early onset
primary care
clinical practice
healthcare
disease activity
interstitial lung disease
drug induced
quality improvement
health insurance
early life
childhood cancer